Viatris (VTRS) is a pharmaceutical company that sells a variety of different drugs. The company plans to offer its first ever dividend and is currently trading at a very low valuation. Does that make it a Buy? Read more to find out.
Author archives: Patrick Ryan
Down 25% YTD, Should Investors Scoop Up Shares of COMPASS Pathways?
Healthcare companies are continuously looking for new treatment options for patients. One in particular, COMPASS Pathways (CMPS), is focused on using psilocybin therapy treat depression. The stock has generated a lot of interest, but is down 25% for th…
Are Shares of Coinbase a Good Buy Under $250?
Coinbase (COIN) is down 32% since its IPO. The losses have intensified in recent days due to weakness in bitcoin. Is it time to buy the dip or is this the beginning of a bearish trend in cryptocurrencies?.
Should Investors Buy the Dip in Trade Desk?
The Trade Desk’s (TTD) stock declined more than 25% in a single day following the company’s latest earnings report. Because the stock dipped 50% below its yearly high, it could be a fantastic buying opportunity for investors who have been patiently wai…
Should Investors Buy the Post-Earnings Dip in Facebook?
Facebook (FB) continues to broaden its horizons by diversifying its revenue streams across social media, virtual reality, online transactions and possibly even its own cryptocurrency at some point in the future. Though the stock has gyrated this month,…
Broadcom vs. Micron: Which 5G Stock is a Better Buy?
The increasing popularity of consumer electronics in general, along with the ongoing rollout of 5G networks, have been driving up the demand for semiconductors amid a global shortage of the commodity. Broadcom (AVGO) and Micron Technology (MU) are two …
Scoop Up These 2 Semiconductor Stocks on Pullbacks
Qorvo (QRVO) and Lam Research Corporation (LRCX) were two stocks that have experienced steep corrections in recent weeks. However, there are signs that the selling pressure may relax and we could see a bounce in certain semiconductor stocks.
Should ChemoCentryx Be in Your Portfolio?
Biotech and pharmaceutical stocks have come to the forefront due to the pandemic. ChemoCentryx (CCXI) aims to provide therapies to combat cancer, autoimmune diseases, and inflammatory disorders, but is it a buy? Read more to find out.
Netflix vs. Spotify: Which Streaming Stock is a Better Buy?
Netflix is the most well known video streaming service and Spotify is the most well-known audio streaming service. As streaming services became extremely popular during the pandemic, both companies benefited. But now that the economy is opening back up…
Avoid These 3 Overvalued Gig Economy Stocks
One of the many negative effects of the pandemic was massive job loss. This led workers to find gig jobs at companies such as Airbnb (ABNB), Uber Technologies (UBER), and Fiverr International (FVRR). Now that the economy is rapidly improving and job pr…